The Russian Federation ranked in Top 20 of Scimago's H-Index for Most Citable Medical Documents
In 2005 Scimago (www.scimagojr.com) introduced the H-index to give weight to the importance, significance and impact of a scientist’s cumulative research contribution in a given field.
The Russian Federation continues to lead the Central Eastern European Region, reflecting the quality of research in the country and the overall impact in the field of medicine.
SPRI is pleased to include the Russian Federation, a country recognized for quality in medical research, among the other high quality countries in which we provide clinical trial services.
“Bringing together science, technology and patients to promote health on a global scale”